POSLUMA^®

From lab to approval

Developed at TUM and TUM University Hospital, patented and licensed by BAYPAT, and advanced by industry partners: POSLUMA^® shows how Bavarian research can become an approved diagnostic for more precise localization of prostate cancer. That is made possible by professionally guided technology transfer.